(Q46007747)

18 December 2017

title

The use of dabigatran immediately after atrial fibrillation ablation. (English)

1 reference

18 December 2017

0 references

1 reference

Roger A Winkle

1

1 reference

18 December 2017

R Hardwin Mead

2

1 reference

18 December 2017

Gregory Engel

3

1 reference

18 December 2017

Melissa H Kong

4

1 reference

18 December 2017

Rob A Patrawala

5

1 reference

18 December 2017

publication date

28 September 2011

1 reference

18 December 2017

Journal of Cardiovascular Electrophysiology

published in

1 reference

18 December 2017

volume

23

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

264-268

1 reference

18 December 2017

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Validation of Clinical Classification Schemes for Predicting Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Atrial fibrillation ablation: "perpetual motion" of open irrigated tip catheters at 50 W is safe and improves outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

New anticoagulants for prevention of stroke in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2011.02175.X

10.1111/J.1540-8167.2011.02175.X

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017